Sales of pelvic floor diagnostics to rise at 6.2% CAGR through 2031, with ultrasound systems commanding maximum demand: FMI

Future Market Insights (FMI) in its recent study highlights key developments in the pelvic floor diagnostics market, affecting growth across various segments including products and end-users. The study predicts the demand for uroflowmetry devices and anal manometry systems to rise at a high pace during the forecast period

  

DUBAI, UAE /PRNewswire/ -- The global pelvic floor diagnostics market is estimated to total US$ 1.8 Bn in 2021, find ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market study. With a favorable demand outlook, FMI projects the pelvic floor diagnostics market to grow at a 6.2% CAGR during the assessment period.

Increment in healthcare expenditure across the globe along with the rising demand for technologically advanced pelvic floor diagnostics are identified as chief factors augmenting growth of the global pelvic floor diagnostics market.

Disruptions in supply chains and lockdown restrictions had caused delayed treatment and diagnostic appointments worldwide, which hampered sales of pelvic floor diagnostic devices in 2020.

However, expedited vaccination drives and increasing research and developments in healthcare technology are anticipated to bode well for the market, which will register year-over-year growth of 7.0% in 2021.

Growing incidence of pelvic disorders among pregnant women and increasing awareness regarding the importance of early diagnosis of pelvic disorders are pressing upon the need for highly effective pelvic floor diagnostics devices.

Overall expansion of healthcare infrastructure has resulted in higher number of diagnostic imaging centers. This also is translating into impressive prospects for sales of latest technologies in ultrasound imaging systems for high-resolution imaging.

These developments, coupled with government policies favoring investment towards research and development will aid the overall market expansion.

FMI has forecast the U.S. to continue dominating the North America pelvic floor diagnostics market. Rising prevalence of pelvic disorders, coupled with rapid adoption of technological advancements in the healthcare sector will continue driving sales in the U.S.

"Besides investment in research and development, market players are expected focus on strategic collaborations to encourage awareness among consumers and offer them advanced healthcare solutions," says the FMI analyst.

Key Takeaways:

  • Sales of ultrasound systems are projected to grow at a 5.7% CAGR, holding 37.7% of the total market share.
  • Applications of pelvic floor diagnostics in hospitals are anticipated to rise at a 5.5% CAGR. The segment is projected to account for 64.2% of the total market share in 2021.
  • The U.S. is estimated to account for 81.5% of the North American pelvic floor diagnostics market share, owing to a subsequent rise in healthcare expenditure.
  • The U.K. will emerge as an attractive market, growing at a 5.8% CAGR over the forecast period.
  • The Brazilian pelvic floor diagnostics market will continue exhibiting high demand, expanding at a 5.5% CAGR.
  • Sales prospects of pelvic floor diagnostics in Mexico are projected to be bright, accounting for 38.4% of the total market share.
  • Japan and South Korea are anticipated to account for 32% and 19% of the total market share respectively.

Prominent Drivers:

  • Surging prevalence of pelvic floor disorders especially among pregnant women has fuelled the demand for advanced healthcare.
  • Rising healthcare spending and favorable reimbursement policies will encourage research initiatives in the market, enabling growth over the forecast period.

Competitive Landscape

Leading players operating in the global pelvic floor diagnostics market are investing in research and development to offer innovative and efficient pelvic floor diagnostic devices. In addition, collaborations, mergers, and acquisitions for production facility expansion will remain a part of lucrative growth strategies. For instance:

  • In March 2021, HOYA Corporation signed a five-year contract with Hitachi for technical advancements and the supply of diagnostics ultrasound systems and ultrasound sensors.
  • In June 2021, Neusoft Corporation unveiled its product portfolio comprising medical imaging for diagnosis including NeuAngio 30F high-speed floor-mounted DSA system.

Leading players operating in Pelvic Floor Diagnostics Market profiled by FMI include:

  • LABORIE Inc.
  • CooperSurgical Inc.
  • SRS Medical
  • Medtronic Plc
  • MEDSPIRA
  • MEDKONSULT medical technology s.r.o.
  • Albyn Medical
  • PENTAX Medical
  • Olympus Medical Systems
  • Stryker's
  • EndoMed Systems
  • Richard Wolf
  • Schölly Fiberoptic
  • Zhuhai Seesheen Medical Technology
  • KARL STORZ
  • Cadwell
  • The Prometheus Group
  • Neurosoft
  • Noraxon USA

More Insights on FMI's Pelvic Floor Diagnostics Market

The latest market study on the pelvic floor diagnostics market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to gain a better perspective of the global pelvic floor diagnostics market potential, its growth, trends, and opportunities, the market is segmented on the basis of:

Product:

  • Urodynamics Systems
  • Uroflowmetry Devices
  • Anal Manometry Systems
  • Cystoscopes
  • Ultrasound Systems
    • Cart/Trolley Based
    • Portable Bladder Ultrasound Systems
  • EMG

End-User:

  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Clinics

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Questions Covered in Pelvic Floor Diagnostics Market Report 

  • The report offers detailed insights into pelvic floor diagnostics market demand outlook for 2021-2031
  • The market study also highlights projected sales growth for pelvic floor diagnostics market between 2021 and 2031
  • Pelvic floor diagnostics market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Pelvic floor diagnostics market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others.

-Ends-

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Abhishek Budholiya
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/pelvic-floor-diagnostics-market
Press Release Source: https://www.futuremarketinsights.com/press-release/pelvic-floor-diagnostics-market 

SOURCE Future Market Insights

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases